Fig. 2From: Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in ChinaOS curve and PFS curve fitting in the experimental group and control group (a, c-experimental group; b, d-control group)Back to article page